Organon Pregnyl 5000 1 amp (1x 5000 IU)

HCG – human chorionic gonadotropin – Pregnyl

This non-steroidal substance is frequently utilized in athletics. HCG is a natural protein hormone produced by the placenta, extracted and purified from the urine of pregnant women.

This hormone is not a male hormone by nature but closely mimics LH (Luetinising Hormone), signaling the testis to enhance testosterone production. This promotes increased testosterone levels in males due to Leydig cells being stimulated. Typically used for treating women with ovarian conditions, HCG also aids men with hypogonadism. Athletes often turn to HCG to stimulate their own testosterone production, which can be diminished after prolonged steroid use. In high doses, steroids can obscure signals to the hypothalamus, weakening its communication with the testicles, leading to atrophy. To counteract this, athletes utilize HCG to sustain stimulation and prevent atrophy.

Upon administration, HCG quickly elevates serum testosterone levels, peaking within two hours post-injection and again two to four days later. It effectively prevents testicular atrophy and leverages the body’s stimuli to boost plasma testosterone during training. Many steroid users report enhanced strength and size gains utilizing HCG in conjunction with steroids, likely due to elevated natural androgens alongside synthetic hormones. Optimal dosage for athletes remains undetermined, though doses of 1000 to 2000 IU weekly are suggested, typically for three-week cycles, followed by at least a month off.

For example, one might administer HCG mid-cycle for two to three weeks and again at the cycle’s end. Prolonged use of HCG may hinder the body’s natural gonadotropin production, reinforcing the preference for shorter cycles. Potential side effects include gynecomastia, water retention, increased libido, mood changes, headaches, and elevated blood pressure. HCG can raise male androgen levels significantly, leading to potential gynecomastia if dosages become excessive. Other symptoms might involve morning sickness-like nausea and vomiting.

Currently, no overdose complications or connections to carcinomas, liver, or renal failure have been reported from HCG use. Initially examined as a potential carrier for the AIDS virus due to its biological activity, recent findings suggest this is not feasible, indicating HCG can aid athletes in managing typical steroid cycle cessation issues. Moreover, it generally does not appear on steroid tests, making it a choice for athletes needing to maintain androgen levels pre-competition. Stored in a refrigerator post-mixing, it remains viable for about ten weeks and is administered intramuscularly. It is often available only via a prescription and can be challenging to source through illicit means.

Pregnyl for pregnancy:

Pregnyl, or human chorionic gonadotropin, is a meticulously purified product derived from the urine of pregnant women. Administered intramuscularly, it duplicates the natural mid-cycle surge of LH, triggering ovulation. Daily intercourse is recommended within 48 hours following the LH surge.

Your physician will guide you on when to engage in intercourse, or potentially advise on an artificial insemination procedure to enhance pregnancy chances.

HOW ARE HUMEGON AND PREGNYL ADMINISTERED?

Humegon is given via intramuscular injection, typically in the buttocks, and cannot be taken orally due to its protein nature, which would lead to digestion in the stomach.

Injections generally commence within the first five days of the menstrual cycle, continuing daily for 7 to 12 days. Your doctor may adjust the drug dosage and administration schedule according to your body’s response. It is common for this to vary from cycle to cycle.

Pregnyl (chorionic gonadotropin for injection, USP) is introduced intramuscularly when your doctor determines specific stimulation criteria have been met. In cases of excessive response, the injection may be omitted.

LENGTH OF TREATMENT

If conception does not occur, Humegon and Pregnyl may be administered again in the subsequent menstrual cycle. Nevertheless, treatment cycles are not always consecutive as therapy is tailored for each individual.

Therapy can extend for up to six cycles, after which alternative options may be discussed with you.

IS IT WORKING?

Once ovulation occurs, progesterone is produced by the ovary, which can be assessed through a blood test approximately seven days post-ovulation. If pregnancy does not result, expect your menstrual period roughly 14 days after hCG injection. If menstruation does not commence, a blood test can verify pregnancy status, and an ultrasound can subsequently monitor pregnancy progress.

CAREFUL MONITORING IS IMPORTANT

Monitoring proves essential for treatment regulation and minimizing side effects, commonly employed methods include dual approaches.

The first method involves daily blood tests measuring estrogen levels. As follicles grow, they release increased estrogen, indicating a more robust ovarian response to Humegon (menotropins for injection).

The second approach, ultrasound, employs sound waves to create images of the ovaries, allowing practitioners to evaluate the count and size of follicles, providing insight into ovulation timing. Attending all blood tests and ultrasounds is crucial, as findings may necessitate treatment adjustments within the current cycle.

SIDE EFFECTS/OTHER CONCERNS ASSOCIATED WITH TREATMENT

Humegon and Pregnyl (chorionic gonadotropin for injection, USP) may provoke both minor and severe side effects, requiring discussion with your doctor before commencing treatment.

Injection sites may occasionally swell or irritate, experiencing some pain during Humegon therapy. Other side effects can include headaches, abdominal discomfort, and moderate ovarian enlargement. Notify your doctor of these symptoms for appropriate treatment adjustments. Pregnyl injections can also cause similar injection site pain accompanied by headaches, irritability, restlessness, depression, fatigue, and fluid retention-related swelling.

Multiple pregnancies pose a concern with fertility medications such as Humegon. Approximately 80% of pregnancies following fertility treatment yield single births, with the majority of multiple births being twins. Nevertheless, instances of three or more pregnancies may occur. Your physician should discuss multiple birth risks prior to treatment initiation.

Discuss any side effects and concerns associated with your treatment plan with your doctor before therapy commencement.

HOW EFFECTIVE IS HUMEGON (MENOTROPINS FOR INJECTION, USP)?

Humegon can induce ovulation in women with irregular cycles or without ovulation. Effectiveness varied based on infertility causes, including tubal condition, semen quality, and age. If pregnancy does not result from Humegon, alternative options will be considered.

CONCLUSION

Many healthy babies result from fertility treatments involving Humegon and Pregnyl (chorionic gonadotropin for injection, USP). Your doctor can address any further inquiries regarding these medications.